enGene Therapeutics Inc. ENGN
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.90% | 18.89% | 29.06% | -18.71% | -21.64% |
| Total Receivables | 305.50% | 448.22% | 759.77% | 115.79% | 194.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.09% | -14.42% | 18.68% | -32.51% | 83.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.72% | 4.17% | -1.33% | 9.72% | -4.00% |
| Total Current Assets | 31.51% | 18.43% | 30.09% | -18.58% | -19.56% |
|
|
|||||
| Total Current Assets | 31.51% | 18.43% | 30.09% | -18.58% | -19.56% |
| Net Property, Plant & Equipment | -8.28% | 195.65% | 224.21% | 250.27% | 251.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.73% | 0.00% | -12.12% | -0.87% | -0.14% |
| Total Assets | 17.42% | 15.33% | 17.90% | -28.83% | -7.99% |
|
|
|||||
| Total Accounts Payable | 6.59% | 14.42% | -6.53% | 373.99% | -16.70% |
| Total Accrued Expenses | 116.85% | 40.20% | 155.82% | 23.32% | 17.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -64.72% | -38.02% | 18.99% | 792.69% | 293.59% |
| Total Finance Division Other Current Liabilities | -43.50% | 14.00% | -64.65% | 164.89% | 192.06% |
| Total Other Current Liabilities | -43.50% | 14.00% | -64.65% | 164.89% | 192.06% |
| Total Current Liabilities | 33.12% | 19.35% | 89.96% | 118.12% | 51.88% |
|
|
|||||
| Total Current Liabilities | 33.12% | 19.35% | 89.96% | 118.12% | 51.88% |
| Long-Term Debt | 42.07% | 24.41% | 14.01% | -31.81% | -18.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.81% | 346.18% | 367.47% | 352.35% | 354.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 29.31% | 33.02% | 54.43% | 39.41% | 22.79% |
|
|
|||||
| Common Stock & APIC | 29.87% | 29.04% | 28.95% | 2.24% | 13.86% |
| Retained Earnings | -39.01% | -41.57% | -43.83% | -46.05% | -39.56% |
| Treasury Stock & Other | -11.75% | -17.75% | 33.96% | 37.42% | -19.00% |
| Total Common Equity | 14.76% | 12.26% | 12.64% | -38.48% | -12.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.76% | 12.26% | 12.64% | -38.48% | -12.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.76% | 12.26% | 12.64% | -38.48% | -12.88% |
|
|
|||||